These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9504645)

  • 21. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study.
    Yarnell JW; Sweetnam PM; Marks V; Teale JD; Bolton CH
    Br Heart J; 1994 Mar; 71(3):293-6. PubMed ID: 8142201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies.
    Bainton D; Miller NE; Bolton CH; Yarnell JW; Sweetnam PM; Baker IA; Lewis B; Elwood PC
    Br Heart J; 1992 Jul; 68(1):60-6. PubMed ID: 1355351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma fibrinogen.
    Lowe GD; Rumley A; Mackie IJ
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):430-40. PubMed ID: 15588432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunonephelometric determination of fibrinogen on citrated or heparinized plasma: comparison with functional Clauss method.
    Bargnoux AS; Dupuy AM; Biron-Andréani C; Schved JF; Cristol JP
    Clin Lab; 2005; 51(5-6):285-8. PubMed ID: 15991802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific assays of hemostasis proteins: fibrinogen.
    Palareti G; Maccaferri M
    Ric Clin Lab; 1990; 20(2):167-76. PubMed ID: 2196664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: analysis of repeatability and agreement of Clauss method within and between six different laboratories.
    Solomon C; Baryshnikova E; Tripodi A; Schlimp CJ; Schöchl H; Cadamuro J; Winstedt D; Asmis L; Ranucci M
    Thromb Haemost; 2014 Jul; 112(1):109-17. PubMed ID: 24633448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study.
    Lowe GD; Rumley A; Sweetnam PM; Yarnell JW; Rumley J
    Thromb Haemost; 2001 Sep; 86(3):822-7. PubMed ID: 11583314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrepancy between fibrinogen concentrations determined by clotting rate and clottability assays during the acute-phase reaction.
    Jensen T; Halvorsen S; Godal HC; Sandset PM; Skjøonsberg OH
    Thromb Res; 2000 Dec; 100(5):397-403. PubMed ID: 11150581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 96-well microfiltration assay for measurement of total clottable fibrinogen.
    Dempfle CE; Keller A; Argirion S; Heene DL
    Thromb Haemost; 1999 Feb; 81(2):264-7. PubMed ID: 10064004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of freeze-drying on the clotting properties of fibrinogen in plasma.
    Jensen T; Halvorsen S; Godal HC; Skjønsberg OH
    Thromb Res; 2002 Mar; 105(6):499-502. PubMed ID: 12091049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct determination of plasma fibrinogen levels by heat precipitation. A comparison of the technique against thrombin clottable fibrinogen with spectrophotometry and radial immuno-diffusion.
    Desvignes P; Bonnet P
    Clin Chim Acta; 1981 Feb; 110(1):9-17. PubMed ID: 6783348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resonance-thrombography indices of the haemostatic process in relation to risk of incident coronary heart disease: 9 years follow-up in the Caerphilly Prospective Heart Disease Study.
    Yu S; Lowe GD; Yarnell JW; Sweetnam PM
    Br J Haematol; 2004 Aug; 126(3):385-91. PubMed ID: 15257711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Copenhagen City Heart Study.
    Kofoed SC; Wittrup HH; Sillesen H; Nordestgaard BG
    Eur Heart J; 2003 Mar; 24(6):567-76. PubMed ID: 12643890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies.
    Sweetnam PM; Thomas HF; Yarnell JW; Baker IA; Elwood PC
    Am J Epidemiol; 1997 Mar; 145(5):416-21. PubMed ID: 9048515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influences of argatroban on five fibrinogen assays.
    Zhang L; Yang J; Zheng X; Fan Q; Zhang Z
    Int J Lab Hematol; 2017 Dec; 39(6):641-644. PubMed ID: 28766891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Faster determination of clottable fibrinogen in human plasma: an improved method and kinetic study.
    Inada Y; Okamoto H; Kanai S; Tamaura Y
    Clin Chem; 1978 Feb; 24(2):351-3. PubMed ID: 627070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemostatic factors and ischaemic heart disease. The Caerphilly study.
    Yarnell JW; Sweetnam PM; Elwood PC; Eastham R; Gilmour RA; O'Brien JR; Etherington MD
    Br Heart J; 1985 May; 53(5):483-7. PubMed ID: 3994861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fibrinogen functional turbidimetric assay.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):84-96. PubMed ID: 18160594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class.
    Murray LJ; Bamford KB; O'Reilly DP; McCrum EE; Evans AE
    Br Heart J; 1995 Nov; 74(5):497-501. PubMed ID: 8562233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clottable to immunological fibrinogen ratio in plasma from control subjects and hyperfibrinogenemic patients.
    Prisco D; Zarone N; Liotta AA; Cellai AP; Comeglio P; Fedi S; Francalanci I; Abbate R
    Haemostasis; 1995; 25(6):257-63. PubMed ID: 8586315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.